Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-07-14 12:39 Tx date 2021-06-28 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-288.72
-72 vol $4.01 each |
0 | |
Filed 2021-07-13 10:40 Tx date 2021-06-28 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-288.72
-72 vol $4.01 each |
||
Filed 2021-07-13 10:40 Tx date 2021-06-28 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-288.72
-72 vol $4.01 each |
0 | |
Filed 2020-12-11 18:12 Tx date 2020-12-07 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$64,049
+15,000 vol $4.27 each |
268,542 | |
Filed 2020-12-11 17:54 Tx date 2020-12-07 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$64,049
+15,000 vol $4.27 each |
||
Filed 2020-12-11 17:54 Tx date 2020-12-07 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$64,049
+15,000 vol $4.27 each |
268,542 | |
Filed 2020-05-29 16:20 Tx date 2020-05-26 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
$3,856,373
+253,542 vol $15.21 each |
253,542 | |
Filed 2020-05-29 16:19 Tx date 2020-05-26 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
$-9,127,512
-253,542 vol $36.00 each |
0 | |
Filed 2020-02-16 11:56 Tx date 2020-02-11 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-8,190
-21 vol $390.00 each |
72 | |
Filed 2020-02-16 11:52 Tx date 2020-02-11 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-85,200
-60 vol $1,420 each |
93 | |
Filed 2019-09-06 12:09 Tx date 2019-09-06 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
37 - Stock split or consolidation
|
-153,447 vol |
153 | |
Filed 2019-09-04 16:51 Tx date 2019-09-04 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
99 - Correction of information
|
$-31,950
-22,500 vol $1.42 each |
153,600 | |
Filed 2019-09-04 16:50 Tx date 2019-09-04 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
99 - Correction of information
|
$-12,168
-31,200 vol $0.39 each |
176,100 | |
Filed 2019-08-05 15:47 Tx date 2019-08-01 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
$-60,500
-50 vol $1,210 each |
253,542 | |
Filed 2019-08-05 15:46 Tx date 2019-08-01 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
$-90,090
-117 vol $770.00 each |
253,592 | |
Filed 2019-08-05 15:44 Tx date 2019-07-05 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+253,709 vol |
253,709 | |
Filed 2019-08-05 15:43 Tx date 2019-07-05 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-253,710,000 vol |
0 | |
Filed 2019-08-05 15:42 Tx date 2019-07-05 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: REER (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
+187 vol |
187 | |
Filed 2019-08-05 15:41 Tx date 2019-07-05 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: REER (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-187,950 vol |
0 | |
Filed 2019-08-05 15:41 Tx date 2019-07-05 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
+446 vol |
446 | |
Filed 2019-08-05 15:40 Tx date 2019-07-05 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-446,400 vol |
0 | |
Filed 2019-08-05 15:40 Tx date 2019-07-05 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+645 vol |
645 | |
Filed 2019-08-05 15:39 Tx date 2019-07-05 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-645,600 vol |
0 | |
Filed 2019-06-20 17:13 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,813
+645,600 vol $0.0152 each |
645,600 | |
Filed 2019-06-20 17:12 Tx date 2017-05-15 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-06-20 17:12 Tx date 2019-06-14 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights
57 - Exercise of rights
|
$-490.656
-32,280 vol $0.0152 each |
0 | |
Filed 2019-06-20 17:11 Tx date 2019-06-14 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights
90 - Change in the nature of ownership
|
$490.66
+32,280 vol $0.0152 each |
32,280 | |
Filed 2019-06-20 17:10 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$5,994
+394,400 vol $0.0152 each |
446,400 | |
Filed 2019-06-20 17:09 Tx date 2019-06-14 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Subscription Rights
90 - Change in the nature of ownership
|
-32,280 vol |
0 | |
Filed 2019-06-20 17:08 Tx date 2019-05-24 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Subscription Rights
56 - Grant of rights
|
$790.40
+52,000 vol $0.0152 each |
52,000 | |
Filed 2019-06-20 11:35 Tx date 2019-06-14 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Subscription Rights
57 - Exercise of rights
|
$-299.744
-19,720 vol $0.0152 each |
0 | |
Filed 2019-06-20 11:34 Tx date 2019-05-24 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Subscription Rights
56 - Grant of rights
|
$299.74
+19,720 vol $0.0152 each |
||
Filed 2019-06-20 11:34 Tx date 2019-05-24 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Subscription Rights
56 - Grant of rights
|
$299.74
+19,720 vol $0.0152 each |
19,720 | |
Filed 2019-06-20 11:33 Tx date 2017-05-15 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Subscription Rights
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-06-20 11:32 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: REER (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$2,720
+179,000 vol $0.0152 each |
187,950 | |
Filed 2019-06-20 11:30 Tx date 2019-06-14 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: REER (Indirect Ownership)
|
Subscription Rights
57 - Exercise of rights
|
$-136.04
-8,950 vol $0.0152 each |
0 | |
Filed 2019-06-20 11:28 Tx date 2019-05-24 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: REER (Indirect Ownership)
|
Subscription Rights
56 - Grant of rights
|
$136.04
+8,950 vol $0.0152 each |
8,950 | |
Filed 2019-06-20 11:27 Tx date 2017-05-15 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: REER (Indirect Ownership)
|
Subscription Rights
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-06-20 11:05 Tx date 2017-05-15 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-06-07 16:25 Tx date 2019-06-04 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,127,548
+253,543,000 vol $0.036 each |
253,710,000 | |
Filed 2019-05-31 15:37 Tx date 2019-05-30 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-85,782
-295,800 vol $0.29 each |
207,300 | |
Filed 2019-02-06 Tx date 2019-02-01 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$85,782
+295,800 vol $0.29 each |
503,100 | |
Filed 2019-02-01 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$48,672
+124,800 vol $0.39 each |
207,300 | |
Filed 2019-02-01 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$36,504
+93,600 vol $0.39 each |
||
Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,090
+117,000 vol $0.77 each |
167,000 | |
Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$36,504
+93,600 vol $0.39 each |
176,100 | |
Filed 2018-05-23 Tx date 2018-05-22 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,700
+15,000 vol $0.78 each |
52,000 | |
Filed 2018-04-03 Tx date 2018-04-03 |
$PLI
Prometic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,800
+20,000 vol $0.74 each |
37,000 | |
Filed 2017-12-20 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$85,200
+60,000 vol $1.42 each |
||
Filed 2017-12-20 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$117,150
+82,500 vol $1.42 each |
82,500 | |
Filed 2017-11-28 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$85,200
+60,000 vol $1.42 each |
60,000 | |
Filed 2017-11-28 Tx date 2017-05-15 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-10-18 Tx date 2017-10-18 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,100
+10,000 vol $1.61 each |
17,000 | |
Filed 2017-08-28 Tx date 2017-08-24 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,500
+50,000 vol $1.21 each |
50,000 | |
Filed 2017-08-28 Tx date 2017-05-15 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-01 Tx date 2017-05-15 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-01 Tx date 2017-06-01 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,280
+7,000 vol $2.04 each |
7,000 | |
Filed 2017-05-26 Tx date 2017-05-15 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: REER (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-26 Tx date 2017-05-25 |
$PLI
ProMetic Life Sciences Inc. |
Leclerc, Martin
5 - Senior Officer of Issuer
Holder: REER (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,168
+8,950 vol $2.03 each |
8,950 |